All Stories

  1. Comparative Analysis of Physicochemical Characteristics of Chondroitin Sulfate from Avian Cartilage: Antioxidant, Anti-inflammatory and Anti-nociceptive Properties
  2. Fucoidan-coated coils improve healing in a rabbit elastase aneurysm model
  3. Optical and X-ray attenuation properties of hafnium oxide nanoparticles surface functionalized with fucoidan: toward the early diagnosis of atherothrombotic diseases
  4. Spatial-Controlled Coating of Pro-Angiogenic Proteins on 3D Porous Hydrogels Guides Endothelial Cell Behavior
  5. Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma
  6. miRNA Delivery by Nanosystems: State of the Art and Perspectives
  7. Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy
  8. Characterization of dextran particle size: How frit-inlet asymmetrical flow field-flow fractionation (FI-AF4) coupled online with dynamic light scattering (DLS) leads to enhanced size distribution
  9. Bioactive refinement for endosaccular treatment of intracranial aneurysms
  10. P-selectin targeting polysaccharide-based nanogels for miRNA delivery
  11. Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo
  12. Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets
  13. Anticoagulant activity of fucosylated chondroitin sulfate isolated from Cucumaria syracusana
  14. Synthesis of cationic quaternized pullulan derivatives for miRNA delivery
  15. Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases
  16. Core-Shell Polymer-Based Nanoparticles Deliver miR-155-5p to Endothelial Cells
  17. Early Detection of Localized Immunity in Experimental Autoimmune Myocarditis Using [99mTc]Fucoidan SPECT
  18. Bimodal Fucoidan-Coated Zinc Oxide/Iron Oxide-Based Nanoparticles for the Imaging of Atherothrombosis
  19. Pharmacology: Drug Delivery
  20. Primary structure and anticoagulant activity of fucoidan from the sea cucumber Holothuria polii
  21. Thin films of binary amorphous Zn-Zr alloys developed by magnetron co-sputtering for the production of degradable coronary stents: A preliminary study
  22. Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses
  23. Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic Events
  24. Characterization and anticoagulant activity of a fucosylated chondroitin sulfate with unusually procoagulant effect from sea cucumber
  25. Co-immobilization of chitosan and dermatan sulfate from Raja montagui skin on polyethylene terephthalate surfaces: Characterization and antibiofilm activity
  26. Gadolinium/terbium hybrid macromolecular complexes for bimodal imaging of atherothrombosis
  27. Synthesis of nanoparticles based on PDMMLA derivative copolymers and study of warfarin encapsulation and controlled release
  28. Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum
  29. Fucoidans in Nanomedicine
  30. In vitro and in vivo hemocompatibility evaluation of a new dermatan sulfate-modified PET patch for vascular repair surgery
  31. Anti-thrombotic properties of a CD31-derived peptide coated on a surface
  32. Polyester-based nanoparticles for the controlled release of bioactive coumarinic derivatives
  33. Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus
  34. Nanocrystals of Zn(Fe)O-based diluted magnetic semi-conductor as potential luminescent and magnetic bimodal bioimaging probes
  35. Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction
  36. Synthesis and Biological Evaluation of New Bisphosphonate–Dextran Conjugates Targeting Breast Primary Tumor
  37. Strong and specific interaction of ultra small superparamagnetic iron oxide nanoparticles and human activated platelets mediated by fucoidan coating
  38. Shape-memory starch for resorbable biomedical devices
  39. A resorbable shape-memory starch-based stent for the treatment of salivary ducts under sialendoscopic surgery
  40. Preparation of cytocompatible luminescent and magnetic nanohybrids based on ZnO, Zn0.95Ni0.05O and core@shell ZnO@Fe2O3 polymer grafted nanoparticles for biomedical imaging
  41. Molecular Imaging of Selectins in Endothelial Activation
  42. Pericardial Processing: Challenges, Outcomes and Future Prospects
  43. Radiolabeled Fucoidan as a P-Selectin Targeting Agent for In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation
  44. Grafting of dermatan sulfate on polyethylene terephtalate to enhance biointegration
  45. In vivo targeted molecular imaging for activated platelets by mri using USPIO-fucoidan in rat abdominal aortic aneuryms model
  46. Synthesis and evaluation of a tri-tyrosine decorated dextran MR contrast agent for vulnerable plaque detection
  47. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula
  48. Fabrication of porous polysaccharide-based scaffolds using a combined freeze-drying/cross-linking process
  49. Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action
  50. Anticoagulant activity of a sulfated polysaccharide from the green alga Arthrospira platensis
  51. Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque
  52. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula)
  53. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate
  54. Biomimetic MRI Contrast Agent for Imaging of Inflammation in Atherosclerotic Plaque of ApoE−/− Mice
  55. A001 Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets
  56. A002 A tyrosine PEG-micelle magnetic resonance contrast agent for the detection of lipid rich areas in the atherosclerotic plaque
  57. Polysaccharides from the skin of the ray Raja radula. Partial characterization and anticoagulant activity
  58. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets
  59. A Novel Cross-linked Poly(vinyl alcohol) (PVA) for Vascular Grafts
  60. A new macromolecular paramagnetic MR contrast agent binds to activated human platelets
  61. Cationized pullulan 3D matrices as new materials for gene transfer
  62. The evaluation of a small-diameter polysaccharide-based arterial graft in rats
  63. CMR 2005: 4.03: A new contrast agent for magnetic resonance imaging of the vascular walls
  64. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels
  65. Retention of transforming growth factor β1 using functionalized dextran-based hydrogels
  66. Poly(N-ethyl-4-vinylpyridinium) bromide as a potential probe to select heparin-like anticoagulant polyanions
  67. Heparin‐like polymers modulate proinflammatory cytokine production by lipopolysaccharide‐stimulated human monocytes
  68. Heparin-like polymers modulate proinflammatory cytokine production by lipopolysaccharide-stimulated human monocytes
  69. Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation:In vitroevaluation with soluble and crosslinked polysaccharide matrices
  70. Interaction of specifically chemically modified dextrans with transforming growth factor β1: potentiation of its biological activity
  71. Anticoagulant properties of dextranmethylcarboxylate benzylamide sulfate (DMCBSu); a new generation of bioactive functionalized dextran
  72. Relationship between antithrombotic activities of fucans and their structure
  73. Relationships between chemical characteristics and anticoagulant activity of low molecular weight fucans from marine algae
  74. Low-molecular-weight dextran derivatives (f-CMDB) enter the nucleus and are better cell-growth inhibitors compared with parent CMDB polymers
  75. Interpolyelectrolyte reactions in solutions of functionalized dextrans with negatively charged groups along the chains
  76. Interpolyelectrolyte reactions in solutions of functionalized dextrans with negatively charged groups along the chains
  77. Effects of the binding of a dextran derivative on fibroblast growth factor 2: secondary structure and receptor-binding studies
  78. Further data on the structure of brown seaweed fucans: relationships with anticoagulant activity
  79. Sulphated polysaccharides derived from dextran: biomaterials for vascular therapy
  80. Anticoagulant activity of dextran derivatives
  81. Carboxymethylation of dextran in aqueous alcohol as the first step of the preparation of derivatized dextrans
  82. Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction
  83. Anticoagulant activity of functionalized dextrans. Structure analyses of carboxymethylated dextran and first Monte Carlo simulations
  84. New investigations on heparin-like derivatized dextrans: CMDBS, synergistic role of benzylamide and sulfate substituents in anticoagulant activity
  85. Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum
  86. Relationships between chemical characteristics and anticomplementary activity of fucans
  87. Synthesis and structure—anticoagulant property relationships of functionalized dextrans: CMDBS
  88. Synthèse et études structurales de nouveaux complexes polyhydroxamiques du fer(III) potentiellement utilisables en imagerie par résonance magnétique nucléaire.Deuxième partie: Études des complexes formés in situ à partir d'acides hydroxamiques. Relaxi...
  89. Synthèse et études structurales de nouveaux complexes polyhydroxamiques du fer(III) potentiellement utilisables en imagerie par résonance magnétique nucléaire. I: Obtention des ligands
  90. The design of magnetic resonance contrast agents: New iron (III) dihydroxamate complexes